Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Mysimba Passes EU Safety Probe, But Currax Must Explore Long-Term Heart Risks
Mar 31 2025
•
By
Neena Brizmohun
The weight management drug, Mysimba, has been approved for use in the EU since March 2015
(Shutterstock)
More from Drug Safety
More from Geography